Literature DB >> 10403168

Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology.

B Baumann1, P Danos, D Krell, S Diekmann, C Wurthmann, H Bielau, H G Bernstein, B Bogerts.   

Abstract

BACKGROUND: The biological basis of unipolar-bipolar dichotomy of mood disorders was investigated in this postmortem study by morphological comparison of the locus coeruleus (LC) as the main source of noradrenergic transmission in the brain.
METHODS: Numbers and the rostro-caudal as well as ventro-dorsal distribution of neuromelanin-containing neurones in the LC were determined in brainstem of 12 patients with bipolar disorder (n = 6) or major depression (n = 6), and 12 normal comparison subjects.
RESULTS: Bipolar patients had significantly more neurones on both sides of the LC as a whole than patients with major depression. Topographical analysis revealed that this difference was restricted to the rostral two thirds and the dorsal part of the LC, in which bipolar patients showed at least a trend to higher neurone numbers as compared to unipolar patients or to controls. LIMITATIONS: Small case numbers.
CONCLUSIONS: Results suggest differences of innervation arising from the LC of bipolar patients as compared to patients with major depression. These first data of brainstem transmitter system morphology in unipolar and bipolar disorder are in line with neuroanatomical studies of other brain regions indicating a biological basis of the unipolar-bipolar dichotomy of mood disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403168     DOI: 10.1016/s0165-0327(98)00168-2

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

Review 1.  Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance.

Authors:  Fleur M Howells; Dan J Stein; Vivienne A Russell
Journal:  Metab Brain Dis       Date:  2012-03-08       Impact factor: 3.584

2.  The Neurobiology of Bipolar Disorder.

Authors:  Allan H Young; Mario F Juruena
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging.

Authors:  Makoto Sasaki; Eri Shibata; Kotaro Ohtsuka; Jin Endoh; Kohsuke Kudo; Shinsuke Narumi; Akio Sakai
Journal:  Neuroradiology       Date:  2009-09-15       Impact factor: 2.804

4.  Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.

Authors:  Amanda R Bolbecker; S Lee Hong; Jerillyn S Kent; Mallory J Klaunig; Brian F O'Donnell; William P Hetrick
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

5.  The neuropathology of bipolar disorder: systematic review and meta-analysis.

Authors:  Paul J Harrison; Lucy Colbourne; Charlotte H Harrison
Journal:  Mol Psychiatry       Date:  2018-08-20       Impact factor: 15.992

6.  Locus coeruleus connectivity alterations in late-life major depressive disorder during a visual oddball task.

Authors:  Inés Del Cerro; Ignacio Martínez-Zalacaín; Andrés Guinea-Izquierdo; Jordi Gascón-Bayarri; Vanesa Viñas-Diez; Mikel Urretavizcaya; Pablo Naval-Baudin; Carlos Aguilera; Ramón Reñé-Ramírez; Isidre Ferrer; José M Menchón; Virginia Soria; Carles Soriano-Mas
Journal:  Neuroimage Clin       Date:  2020-10-27       Impact factor: 4.881

Review 7.  Global Signal Topography of the Human Brain: A Novel Framework of Functional Connectivity for Psychological and Pathological Investigations.

Authors:  Yujia Ao; Yujie Ouyang; Chengxiao Yang; Yifeng Wang
Journal:  Front Hum Neurosci       Date:  2021-03-25       Impact factor: 3.169

8.  A voxel-based diffusion tensor imaging study of white matter in bipolar disorder.

Authors:  Katie Mahon; Jinghui Wu; Anil K Malhotra; Katherine E Burdick; Pamela DeRosse; Babak A Ardekani; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.